Key Points
GMO Product Platform stock surges 2.86% to ¥1,796 on earnings beat.
Revenue growth accelerates 35.66% with gross profit up 50.29%.
Meyka AI rates 3695.T with B grade, projects ¥2,547.67 yearly target.
Technical overbought signals and elevated P/E ratio warrant caution despite positive momentum.
GMO Product Platform, Inc. (3695.T) jumped 2.86% to ¥1,796 on May 14, 2026, following earnings announcement on the Japan Exchange (JPX). The Tokyo-based specialty business services company, which operates the Asia Cloud Panel audience engagement platform, delivered solid financial performance. The stock gained ¥50 in intraday trading, signaling investor confidence in the company’s data collection and survey solutions. With a market cap of ¥7.8 billion, 3695.T continues to serve enterprise clients across Asia seeking agile market research capabilities.
Stock Performance and Technical Strength
3695.T stock demonstrated bullish momentum on May 14, closing near session highs after the earnings announcement. The 2.86% gain pushed the stock above its 50-day moving average of ¥1,687.14, signaling renewed buying interest from institutional investors.
Technical indicators reveal overbought conditions with RSI at 66.35 and Money Flow Index at 85.32, suggesting strong accumulation. The stock traded 4,900 shares against an average volume of 3,233, indicating above-average participation. Bollinger Bands show the price near the upper band at ¥1,734.05, while the Awesome Oscillator reads 26.67, confirming positive momentum. Year-to-date, 3695.T has declined 17.32%, but the recent bounce suggests potential reversal.
Financial Metrics and Valuation
GMO Product Platform trades at a P/E ratio of 42.27, reflecting premium valuation relative to sector peers in Japan’s Industrials sector, which averages 18.2x earnings. The company’s EPS of ¥41.9 demonstrates solid profitability, though earnings per share growth has contracted 62.69% year-over-year due to share dilution.
Key financial strengths include a price-to-sales ratio of 1.14, below the sector average of 1.03, and a dividend yield of 3.36% with annual payout of ¥59.52 per share. The balance sheet shows strong liquidity with a current ratio of 1.18 and cash per share of ¥1,327.33. However, debt-to-equity stands at 0.27, indicating moderate leverage. Track 3695.T on Meyka for real-time valuation updates and analyst consensus shifts.
Growth Drivers and Market Position
Revenue growth accelerated 35.66% year-over-year, driven by expanding demand for audience engagement platforms across Asia. Gross profit surged 50.29%, demonstrating operational leverage as the company scales its Asia Cloud Panel network. Operating income climbed 44.89%, reflecting improved efficiency in survey service delivery and data collection solutions.
The company operates in Japan’s Industrials sector, which commands ¥292 trillion in total market capitalization across 835 companies. GMO Product Platform’s specialty business services niche—focused on market research automation—positions it favorably amid rising corporate demand for agile data insights. However, net income declined 15.02% due to higher tax rates at 41.48%, partially offsetting operational gains.
Market Sentiment and Technical Outlook
Trading activity on May 14 reflected strong institutional interest, with volume 51.6% above average. The CCI indicator at 290.43 signals overbought conditions, suggesting potential consolidation before the next leg higher. Stochastic %K at 62.66 indicates momentum remains positive but approaching resistance.
Meyka AI rates 3695.T with a grade of B, suggesting a HOLD recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The DCF score of 5 indicates strong intrinsic value, while the P/E score of 1 reflects valuation concerns. Meyka AI’s forecast model projects ¥2,547.67 within 12 months, implying 41.8% upside from current levels. These grades are not guaranteed and we are not financial advisors.
Final Thoughts
GMO Product Platform’s 2.86% surge reflects positive market reception to earnings results and accelerating revenue growth of 35.66%. The stock’s technical setup shows strength with RSI above 66 and volume outpacing averages, though overbought signals warrant caution. Meyka AI’s B grade and ¥2,547.67 yearly forecast suggest meaningful upside potential, supported by robust gross profit expansion and market position in Asia’s growing data services sector. Investors should monitor the company’s ability to sustain revenue momentum while managing elevated tax rates. The 3.36% dividend yield provides income support for long-term holders. Forecasts are model-based projections and not guarantees.
FAQs
GMO Product Platform announced earnings on May 14, delivering strong revenue growth of 35.66% and gross profit expansion of 50.29%. The positive results drove institutional buying, pushing the stock to ¥1,796 and above its 50-day moving average.
3695.T trades at a P/E ratio of 42.27, which is significantly higher than the Industrials sector average of 18.2x. This premium valuation reflects investor expectations for continued growth in audience engagement platforms.
Meyka AI’s forecast model projects ¥2,547.67 within 12 months, implying 41.8% upside from the current ¥1,796 price. This forecast factors in financial growth, sector trends, and analyst consensus. Forecasts are model-based projections and not guarantees.
Yes, 3695.T offers a dividend yield of 3.36% with an annual payout of ¥59.52 per share. The company maintains a consistent dividend policy, making it attractive for income-focused investors seeking exposure to Japan’s data services sector.
Key risks include elevated P/E valuation at 42.27x, overbought technical conditions with RSI at 66.35, and earnings per share contraction of 62.69% due to share dilution. Additionally, high effective tax rate of 41.48% pressures net income growth despite strong revenue expansion.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)